DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.

Raleigh D, Liu SJ, Majd N, Zou C, Congivaram H, Najem H, Youngblood M, Wang IC, Sengelmann S, Raval K, Jiang J, Foster K, Casey-Clyde T, Pak J, Pan S, Payne E, Lin K, Vasudevan H, Thompson M, Ozawa T, Mirchia K, Berger M, Weiss W, Heimberger A, de Groot J, Gilbert L